NALOXONE Side Effects

6248662-0 | Convulsion, Hypertension
on Jun 24, 2009 Female patient from UNITED STATES , 74 years of age, was diagnosed with sedation and was treated with Naloxone (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hypertension. Naloxone dosage: 0.4 Mg Iv X 1.

6038058-9 | Flushing, Somnolence
Patient was taking Naloxone (View Usage). Patient had the following side effects: flushing, somnolence on Jan 13, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with somnolence and. Naloxone dosage: 0.4mg Once Iv.

5849300-9 | Foaming At Mouth, Loss Of Consciousness, Miosis, Neuroleptic Malignant Syndrome
Adverse event was reported on Aug 04, 2008 by a Female patient taking Naloxone (View Usage) (Dosage: 0.4 Mg, 3 Doses, Intravenous) was diagnosed with overdose and. Location: UNITED STATES , 57 years of age, weighting 121.3 lb, After Naloxone was administered, patient had the following side effects: foaming at mouth, loss of consciousness, miosis, neuroleptic malignant syndrome. During the same period patient was treated with FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ). Patient was hospitalized.

5813600-9 | Hypotension, Respiratory Disorder, Tremor
on Jul 16, 2008 Male patient from UNITED STATES , 51 years of age, was treated with Naloxone (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, respiratory disorder, tremor. Naloxone dosage: See Above. Patient was hospitalized.


4960366-0 | Gastroenteritis
on Mar 14, 2006 Male patient from GERMANY , 56 years of age, weighting 235.9 lb, was diagnosed with back pain (What is back pain?) and was treated with Naloxone (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?). Naloxone dosage: 20 Mg, Bid, Oral. During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TIMO COMOD (TIMOLOL MALEATE) (View Timo-comod (timolol Maleate) Review and Timo-comod (timolol Maleate) Label ), CITALOPRAM (CITALOPRAM) (View Citalopram (citalopram) Review and Citalopram (citalopram) Label ), DOLO POSTERINE (CINCHOCAINE HYDROCHLORIDE, ALLANTOIN, DIPHENYLPYRALINE (View Dolo Posterine (cinchocaine Hydrochloride, Allantoin, Diphenylpyraline Review and Dolo Posterine (cinchocaine Hydrochloride, Allantoin, Diphenylpyraline Label ), POSTERISAN FORTE (HYDROCORTISONE, PHENOL, LANOLIN, PARAFFIN SOFT, ESCH (View Posterisan Forte (hydrocortisone, Phenol, Lanolin, Paraffin Soft, Esch Review and Posterisan Forte (hydrocortisone, Phenol, Lanolin, Paraffin Soft, Esch Label ). Patient was hospitalized.

4895113-4 | Confusional State, Feeling Abnormal, Loss Of Consciousness, Miosis, Respiratory Arrest, Respiratory Failure, Tremor
Patient was taking Naloxone (View Usage). After Naloxone was administered, patient had the following side effects: confusional state, feeling abnormal, loss of consciousness, miosis, respiratory arrest, respiratory failure, tremor on Jan 17, 2006 from NORWAY Additional patient health information: Male patient , 25 years of age, was diagnosed with overdose and. Naloxone dosage: 0.8 Mg 2 Doses Im/iv. During the same period patient was treated with HEROIN (View Heroin Review and Heroin Label ), ROHYPNOL (FLUNITRAZEPAM) HOFFMAN LAROCHE, INC. (View Rohypnol (flunitrazepam) Hoffman-laroche, Inc. Review and Rohypnol (flunitrazepam) Hoffman-laroche, Inc. Label ), ALCOHOL (Po) (View Alcohol Review and Alcohol Label ). Patient was hospitalized.

4895110-9 | Confusional State, Headache, Loss Of Consciousness, Miosis, Overdose, Respiratory Failure, Restlessness
Adverse event was reported on Jan 17, 2006 by a Male patient taking Naloxone (View Usage) (Dosage: 0.8 Mg Once Im) was diagnosed with overdose and. Location: NORWAY , 25 years of age, Patient experienced the following unwanted or unexpected effects: confusional state, headache (What is headache?), loss of consciousness, miosis, overdose, respiratory failure, restlessness. During the same period patient was treated with HEROIN (View Heroin Review and Heroin Label ), ROHYPNOL (FLUNITRAZEPAM) HOFFMAN LAROCHE, INC. (View Rohypnol (flunitrazepam) Hoffman-laroche, Inc. Review and Rohypnol (flunitrazepam) Hoffman-laroche, Inc. Label ). Patient was hospitalized.

4852820-7 | Dysphagia, Dyspnoea, Nausea, Retching, Throat Tightness
on Dec 12, 2005 Male patient from UNITED STATES , 82 years of age, weighting 224.4 lb, was diagnosed with reversal of opiate activity, sedation and was treated with Naloxone (View Usage). Patient had the following side effects: dysphagia, dyspnoea, nausea (What is nausea?), retching, throat tightness. Naloxone dosage: 0.4 Mg Once Iv.

4732561-7 | Convulsion
on Aug 01, 2005 Male patient from UNITED STATES , 45 years of age, weighting 128.1 lb, was treated with Naloxone (View Usage). After Naloxone was administered, patient had the following side effects: convulsion. Naloxone dosage: .

4726979-6 | Convulsion, Loss Of Consciousness, Mental Status Changes, Overdose
Patient was taking Naloxone (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, loss of consciousness, mental status changes, overdose on Jul 26, 2005 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with reversal of opiate activity, back pain (What is back pain?) and. Naloxone dosage: 0.8mg Iv Once. During the same period patient was treated with MS CONTIN (60mg Po Q8h) (View Ms Contin Review and Ms Contin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TYLENOL NO. 4 (View Tylenol No. 4 Review and Tylenol No. 4 Label ), TERAZOSIN (View Terazosin Review and Terazosin Label ), MORPHINE (View Morphine Review and Morphine Label ), CELEXA (View Celexa Review and Celexa Label ), REMERON (View Remeron Review and Remeron Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

4703407-8 | Cerebral Ventricle Dilatation, Congenital Anomaly, Microcephaly, Porencephaly
Adverse event was reported on Jun 16, 2005 by a Female patient taking Naloxone (View Usage) (Dosage: 0.4 Mg 2 Doses T-plac) . Location: , weighting 4.48 lb, Patient had the following side effects: cerebral ventricle dilatation, congenital anomaly, microcephaly, porencephaly. During the same period patient was treated with METHADONE HCL (35 Mg Daily T-plac) (View Methadone Hcl Review and Methadone Hcl Label ), DIAZEPAM (20 Mg T-plac) (View Diazepam Review and Diazepam Label ).

4692022-0 | Acute Respiratory Distress Syndrome, Agitation, Hypoxia, Loss Of Consciousness, Phlebothrombosis, Pneumonia Aspiration, Pulmonary Toxicity
on Jun 03, 2005 Male patient from , 23 years of age, was treated with Naloxone (View Usage). After Naloxone was administered, patient had the following side effects: acute respiratory distress syndrome, agitation, hypoxia, loss of consciousness, phlebothrombosis, pneumonia aspiration, pulmonary toxicity. Naloxone dosage: Iv. Patient was hospitalized.